MimiVax Overview
- Founded
-
2012
- Status
-
Private
- Employees
-
3
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$5M
- Investors
-
4
MimiVax General Information
Description
Developer of immunotherapeutic vaccines and targeted therapies intended to control tumor growth and recurrence. The company's vaccines use survivin-targeting technology to target a cell-survival protein present in most cancers, enabling healthcare providers to disrupt cancer, cure patients and increase patient survival rates.
Contact Information
Website
www.mimivax.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
- Elm & Carlton Streets
- Buffalo, NY 14263
- United States
+1 (716) 000-0000
MimiVax Timeline
MimiVax Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Later Stage VC | 10-Dec-2021 | $5M | 0000 | Completed | Generating Revenue | |
| 6. Later Stage VC | 24-Jun-2020 | 000 | 0000 | Completed | Clinical Trials - Phase 2 | |
| 5. Later Stage VC | 02-Aug-2019 | 0000 | Cancelled | Clinical Trials - Phase 2 | ||
| 4. Early Stage VC | 000 | 000 | Completed | Clinical Trials - Phase 1 | ||
| 3. Early Stage VC (Series A) | 25-Aug-2015 | 00.000 | 000 | Completed | Startup | |
| 2. Grant | 01-Mar-2015 | $2M | $450K | Completed | Startup | |
| 1. Seed Round | 01-Jan-2012 | $450K | $450K | Completed | Startup |
MimiVax Executive Team (4)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Michael Ciesielski Ph.D | Co-Founder, Chief Executive Officer & Chief Scientific Officer | ||
| Robert Fenstermaker MD | Co-Founder & Chief Medical Officer | ||
| Anil Goyal Ph.D | Chief Business Officer | ||
| Scott Friedman JD | Co-Founder, General Counsel & Board Member |
MimiVax Board Members (4)
| Name | Representing | Role | Since |
|---|---|---|---|
| David Hohn MD | Self | Board Member | 000 0000 |
| Doug Plessinger | Self | Board Member | 000 0000 |
| Jeremy Jacobs Jr. | Buffalo Capital Partners | Chairman | 000 0000 |
| Scott Friedman JD | Self | Co-Founder, General Counsel & Board Member | 000 0000 |
MimiVax Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
MimiVax Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Jerry Jacobs | Angel (individual) | Minority | 000 0000 | 000000 0 | |
| Varia Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Buffalo Capital Partners | Impact Investing | Minority | 000 0000 | 000000 0 | |
| Roswell Park Cancer Institute | Corporation | Minority | 000 0000 | 000000 0 |